The Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) conducts basic research in the field of molecular pharmacology. Interdisciplinary research combining the research disciplines biology, chemistry, pharmacology and physics addresses molecular pharmacological issues. Investigation of molecular processes of the human organism is employed to identify target molecules, mostly proteins, and bioactive substances that might serve as tools for research or as starting point for novel diagnostic or therapeutic procedures. The ultimate goal is to find novel bioactive substances from which new drugs can be developed.
Scientists from the FMP's three sections "Molecular Physiology and Cell Biology", "Structural Biology", and "Chemical Biology" are working intensively to pursue this objective in various projects within the institute and with other research groups in the city, the region, country, and worldwide. Volker Haucke, Director at the FMP, therefore welcomes the networking initiative Berlin Research 50: "BR50 is an ideal platform to bring together the creative forces in Berlin's non-university science community. Joint projects will enable us to use the full potential of our institutes and thus provide society with future-oriented scientific results".